| Active substance |
Febuxostat |
| Also known as |
Febutaz, Adenuric |
| Blood pressure |
No significant effect |
| Chemical name |
2-(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid |
| Dosage (medical) |
Typically 40 mg or 80 mg once daily |
| Dosage (sports) |
Not applicable |
| Effects |
Decreases serum uric acid levels |
| Formula |
C16H16N2O3S |
| Half-life |
Approximately 5 to 8 hours |
| Hepatotoxicity |
Possible, requires monitoring of liver function |
| Lab Test |
Monitoring of uric acid levels, liver function tests |
| Main action |
Reduces uric acid production |
| Side effects |
Liver function abnormalities, nausea, joint pain, rash |
| Storage conditions |
Store at room temperature, away from moisture and heat |
| Strength |
40mg |
| Substance class |
Xanthine oxidase inhibitor |
| Trade name |
Uloric |
| Use in sports |
Not typically used in sports |
| Water Retention |
No significant effect |
| Manufacturer |
Sun Pharma Laboratories Ltd. |
| Packing |
15 tabs/blister |
